Dog påviste den anden undersøgelse, der undersøgte vævsforsegling hos 299 patienter (148 Tachosil, 151 standard kirurgisk behandling), med demonstreret intraoperativ luftlækage, at TachoSil var signifikant bedre end standardbehandlingen.
However, the second study investigating tissue sealing in 299 patients (148 TachoSil, 151 standard surgical treatment) with demonstrated intraoperative air leakage showed the superiority of TachoSil compared to standard treatment.